Minireviews
Copyright ©The Author(s) 2021.
World J Diabetes. Jun 15, 2021; 12(6): 839-854
Published online Jun 15, 2021. doi: 10.4239/wjd.v12.i6.839
Table 4 List of epidemiological studies on the role of angiotensin-converting enzyme 2 in diabetes, hypertension, cardiovascular disease, and acute lung injury
Disease
Source country
Patients
Main findings
Ref.
DiabetesCanadaRenal biopsies from 13 diabetic and 8 control patientsACE2 mRNA and protein expression were significantly reduced in both the glomeruli and proximal tubules of the diabetic patientsReich et al[53]
Japan66 nondiabetic and 8 diabetic patients with biopsy-proven renal diseasesACE2 mRNA expression was not significantly changed in the diabetic patientsKonoshita et al[54]
China275 Uygur T2D patients and 272 nondiabetic Uygur individualsACE2 SNPs rs1978124, rs2048683, rs2074192, rs233575, rs4240157, rs4646156, rs4646188, and rs879922 were associated with T2DLiu et al[55]
HypertensionAustralia503 Caucasian subjects with type 2 diabetesGenetic variation in ACE2 was associated with hypertension and reduced systolic function in men, and hypertension and increased LV mass in womenPatel et al[65]
China275 Uygur T2D patients and 272 nondiabetic Uygur individualsACE2 SNPs rs2048683, rs233575, rs4240157, rs4646156, rs4646188, and rs879922 were associated with increased SBP, while rs2074192, rs4646188, and rs879922 were associated elevated DBPLiu et al[55]
China402 hypertensive patients and 233 normotensive individualsACE2 variant rs2074192 was associated with EH, while rs4240157, rs4646155, and rs4830542 were associated with EH- and hypertension-related atrial fibrillation and left atrial remodelingLuo et al[66]
China3408 untreated hypertensive patientsThe T allele of ACE2 rs2106809 was found to confer a 1.6-fold risk for hypertension in womenFan et al[67]
China96 patients with EH and 96 healthy controlsAberrant methylation of the ACE2 promoter may be associated with EH riskFan et al[68]
Cardiovascular diseaseUnited States11 individuals with dilated cardiomyopathy, 15 individuals with hypertrophic cardiomyopathy, and 16 controls with nonfailing hearts from the Penn Human Heart Tissue BiobankACE2 expression was downregulated in fibroblasts, pericytes, and vascular smooth muscle but upregulated in cardiomyocytes in dilated cardiomyopathy and hypertrophic cardiomyopathyFan et al[67]
Hungary45 healthy individuals, 239 hypertensiveindividuals,141 patients with heart failure (HF) and reduced ejection fraction (HFrEF), and 47 patients with HF and preserved ejection fraction (HFpEF)ACE2 activity was further increased in HFrEF patients. Serum ACE2 activity was negatively correlated with left ventricular systolic function in HFrEFÚri et al[74]
United States113 patients with chronic systolic heart failureElevated plasma soluble ACE2 (sACE2) activity was associated with greater severity of myocardial dysfunction and was an independent predictor of adverse clinical eventsEpelman et al[75]
14 countries across five continents10753 Prospective Urban Rural Epidemiology participantsIncreased concentration of plasma ACE2 was associated with a higher risk of incident heart failure, myocardial infarction, stroke, and diabetesNarula et al[76]
ItalyHealthy subjects (C) and EH and Bartter's/Gitelman's (BS/GS) patientsACE2 was significantly elevated in BS/GS compared with either C or EHCalò et al[77]
China275 Uygur T2D patients and 272 nondiabetic Uygur individualsACE2 SNPs rs2074192 and rs879922 were associated with carotid arteriosclerosis stenosis and ACE2 SNPs rs2048683, rs4240157, rs4646156, rs4646188, and rs879922 were linked to heavier left heart remodelingLiu et al[55]
Acute lung injuryUnited States44 patients with acute respiratory distress syndrome (ARDS)GSK2586881, a rhACE2, was well-tolerated in patients with ARDS, and has been found to reduce Ang II levels and increase Ang 1-7 levelsKhan et al[94]